Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4018796 | Journal of Cataract & Refractive Surgery | 2009 | 9 Pages |
Abstract
Difluprednate given 2 or 4 times a day cleared postoperative inflammation and reduced pain rapidly and effectively. There were no serious ocular adverse events. Fewer adverse events were reported in the difluprednate-treated groups than in the placebo group.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Michael S. MD, Steven M. MD, David L. MD, Roger MD, Robert S. PhD, Difluprednate Ophthalmic Emulsion 0.05% (Durezol) Study Group Difluprednate Ophthalmic Emulsion 0.05% (Durezol) Study Group,